Barrington Research Reiterates "Outperform" Rating for Concentrix (NASDAQ:CNXC)

Key Points

• Barrington Research reiterated a "Outperform" rating on Concentrix and set a $62 price target, implying roughly a 94% upside from the stock's previous close.
• Analyst sentiment is mixed (marketbeat consensus: Hold, average target $63.75); the company beat quarterly EPS estimates ($2.95 vs. $2.93) with 4.3% revenue growth but still reports a negative net margin of -13.02% and a debt-to-equity ratio of 1.67.

Concentrix (NASDAQ:CNXC - Get Free Report)'s stock had its "outperform" rating restated by Barrington Research in a report released on Tuesday,Benzinga reports. They currently have a $62.00 target price on the stock. Barrington Research's price target suggests a potential upside of 93.99% from the stock's previous close.

A number of other equities research analysts also recently commented on CNXC. Wall Street Zen raised Concentrix from a "hold" rating to a "buy" rating in a report on Saturday, February 14th. Weiss Ratings downgraded shares of Concentrix from a "hold (c-)" rating to a "sell (d)" rating in a report on Thursday, January 29th. Finally, Robert W. Baird set a $52.00 price target on shares of Concentrix in a research report on Wednesday, January 14th. Three research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Concentrix presently has an average rating of "Hold" and a consensus target price of $63.75.

Concentrix Price Performance

NASDAQ CNXC opened at $31.96 on Tuesday. The company has a market cap of $1.96 billion, a price-to-earnings ratio of -1.53, a PEG ratio of 0.33 and a beta of 0.50. The company has a debt-to-equity ratio of 1.67, a current ratio of 1.40 and a quick ratio of 1.40. The stock's fifty day moving average price is $36.70 and its 200 day moving average price is $41.24. Concentrix has a 1 year low of $29.35 and a 1 year high of $66.00.

Concentrix (NASDAQ:CNXC - Get Free Report) last issued its quarterly earnings results on Tuesday, January 13th. The company reported $2.95 EPS for the quarter, topping analysts' consensus estimates of $2.93 by $0.02. The company had revenue of $2.55 billion during the quarter, compared to analysts' expectations of $2.54 billion. Concentrix had a positive return on equity of 16.91% and a negative net margin of 13.02%.The firm's revenue was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.26 EPS. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. As a group, equities research analysts forecast that Concentrix will post 10.11 earnings per share for the current year.

Insider Activity

In other news, CEO Christopher A. Caldwell bought 1,000 shares of the stock in a transaction dated Thursday, January 29th. The shares were acquired at an average cost of $37.07 per share, with a total value of $37,070.00. Following the purchase, the chief executive officer directly owned 362,075 shares in the company, valued at $13,422,120.25. The trade was a 0.28% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.90% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Concentrix

Institutional investors and hedge funds have recently modified their holdings of the business. Osaic Holdings Inc. grew its holdings in Concentrix by 13.4% in the second quarter. Osaic Holdings Inc. now owns 2,222 shares of the company's stock valued at $118,000 after purchasing an additional 263 shares during the period. State of Wyoming raised its stake in shares of Concentrix by 6.2% during the 4th quarter. State of Wyoming now owns 5,029 shares of the company's stock worth $209,000 after buying an additional 293 shares during the period. Deutsche Bank AG lifted its position in shares of Concentrix by 4.7% during the 4th quarter. Deutsche Bank AG now owns 6,767 shares of the company's stock valued at $281,000 after buying an additional 303 shares in the last quarter. Clearstead Advisors LLC lifted its position in shares of Concentrix by 26.4% during the 3rd quarter. Clearstead Advisors LLC now owns 1,650 shares of the company's stock valued at $76,000 after buying an additional 345 shares in the last quarter. Finally, Brevan Howard Capital Management LP grew its stake in Concentrix by 4.5% in the 2nd quarter. Brevan Howard Capital Management LP now owns 8,951 shares of the company's stock valued at $473,000 after acquiring an additional 384 shares during the period. Hedge funds and other institutional investors own 90.34% of the company's stock.

About Concentrix

Concentrix Inc NASDAQ: CNXC is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.